Long-term prognosis in patients with psoriasis von Gulliver, W.

Volltext

Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others von Puig, Lluís

Volltext

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials von Jemec, G.B.E., Okun, M.M., Forman, S.B., Gulliver, W.P.F., Prens, E.P., Mrowietz, U., Armstrong, A.W., Geng, Z., Gu, Y., Williams, D.A., Teixeira, H.D., Kimball, A.B.

Volltext

The Immunogenicity of Biologic Therapies von Garcês, Sandra, Demengeot, Jocelyne

Volltext

The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials von Fleming, P., Bai, J.W., Pratt, M., Sibbald, C., Lynde, C., Gulliver, W.P.

Volltext

Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies von Bobotsis, R., Gulliver, W.P., Monaghan, K., Lynde, C., Fleming, P.

Volltext

Weight change in patients with psoriasis using tumour necrosis factor‐α inhibitors von Muntyanu, A., Gulliver, W.P., Fleming, P.

Volltext

Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials von Partridge, A.C.R., Bai, J.W., Rosen, C.F., Walsh, S.R., Gulliver, W.P., Fleming, P.

Volltext

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group von Zouboulis, C.C., Bechara, F.G., Dickinson‐Blok, J.L., Gulliver, W., Horváth, B., Hughes, R., Kimball, A.B., Kirby, B., Martorell, A., Podda, M., Prens, E.P., Ring, H.C., Tzellos, T., Zee, H.H., Straalen, K.R., Vossen, A.R.J.V., Jemec, G.B.E.

Volltext

Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies von Tzellos, T., Zouboulis, C.C., Gulliver, W., Cohen, A.D., Wolkenstein, P., Jemec, G.B.E.

Volltext

Cumulative life course impairment in psoriasis: patient perception of disease‐related impairment throughout the life course von Warren, R.B., Kleyn, C.E., Gulliver, W.P.

Volltext

The expected missing heritability of hidradenitis suppurativa in perspective von Straalen, K.R., Gulliver, W.

Volltext

Development of rapid, reliable and novel severity measures for psoriasis and eczema von Gulliver, W. P., Yadav, O. P., Gulliver, S., Cousens, M.

Volltext

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR) von Kimball, A.B., Leonardi, C., Stahle, M., Gulliver, W., Chevrier, M., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Menter, A.

Volltext

Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review von Fleming, P., Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Siu, S., Kraft, J., Lynde, C., Pope, J.E., Keeling, S., Dutz, J., Bessette, L., Bissonnette, R., Haraoui, B., Gulliver, W.P.

Volltext

Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects von Shea, J.L, King, M.T.C, Yi, Y, Gulliver, W, Sun, G

Volltext

Adverse Reactions to Biologics in Psoriasis von Lockwood, Stephen J., Prens, Lisette M., Kimball, Alexa B.

Volltext

Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa von Gulliver, W.P., Jemec, G.B.E., Baker, K.A.

Volltext

Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study von Gulliver, W., Alavi, A., Wiseman, M.C., Gooderham, M.J., Rao, J., Alam, M.S., Papp, K.A., Desjardins, O., Jean, C.

Volltext

Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab) von Hwang, Shelley Ji Eun, Fernández-Peñas, Pablo

Volltext